Annual SGA
$14.04 M
+$1.44 M+11.38%
December 31, 2023
Summary
- As of February 8, 2025, ATOS annual SGA is $14.04 million, with the most recent change of +$1.44 million (+11.38%) on December 31, 2023.
- During the last 3 years, ATOS annual SGA has risen by +$6.04 million (+75.56%).
- ATOS annual SGA is now at all-time high.
Performance
ATOS SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$2.97 M
-$579.00 K-16.30%
September 30, 2024
Summary
- As of February 8, 2025, ATOS quarterly SGA is $2.97 million, with the most recent change of -$579.00 thousand (-16.30%) on September 30, 2024.
- Over the past year, ATOS quarterly SGA has dropped by -$28.00 thousand (-0.93%).
- ATOS quarterly SGA is now -36.39% below its all-time high of $4.67 million, reached on June 30, 2019.
Performance
ATOS Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$782.11 M
-$26.91 M-3.56%
September 30, 2024
Summary
- As of February 8, 2025, ATOS TTM SGA is -$782.11 million, with the most recent change of -$26.91 million (-3.56%) on September 30, 2024.
- Over the past year, ATOS TTM SGA has dropped by -$795.95 million (-5754.79%).
- ATOS TTM SGA is now -203152.08% below its all-time high of -$384.80 thousand.
Performance
ATOS TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
ATOS Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +11.4% | -0.9% | -5754.8% |
| 3 y3 years | +75.6% | +0.7% | -7784.9% |
| 5 y5 years | +94.4% | +0.7% | -7784.9% |
ATOS Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +24.1% | -27.3% | at low | -61.3% | at low |
| 5 y | 5-year | at high | +75.6% | -27.3% | +73.0% | -120.6% | at low |
| alltime | all time | at high | +1202.7% | -36.4% | >+9999.0% | <-9999.0% | at low |
Atossa Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $2.97 M(-16.3%) | $13.12 M(-0.2%) |
| Jun 2024 | - | $3.55 M(+9.9%) | $13.15 M(-3.9%) |
| Mar 2024 | - | $3.23 M(-4.0%) | $13.69 M(-2.5%) |
| Dec 2023 | $14.04 M(+11.4%) | $3.37 M(+12.1%) | $14.04 M(+1.5%) |
| Sep 2023 | - | $3.00 M(-26.6%) | $13.83 M(-0.3%) |
| Jun 2023 | - | $4.09 M(+13.9%) | $13.88 M(+7.2%) |
| Mar 2023 | - | $3.59 M(+13.9%) | $12.95 M(+2.7%) |
| Dec 2022 | $12.61 M(+11.5%) | $3.15 M(+3.5%) | $12.61 M(+1.2%) |
| Sep 2022 | - | $3.04 M(-3.7%) | $12.46 M(+0.8%) |
| Jun 2022 | - | $3.16 M(-2.6%) | $12.36 M(-0.3%) |
| Mar 2022 | - | $3.25 M(+8.2%) | $12.41 M(+9.7%) |
| Dec 2021 | $11.31 M(+41.4%) | $3.00 M(+1.7%) | $11.31 M(+11.1%) |
| Sep 2021 | - | $2.95 M(-7.9%) | $10.18 M(+12.1%) |
| Jun 2021 | - | $3.21 M(+48.9%) | $9.07 M(+11.3%) |
| Mar 2021 | - | $2.15 M(+15.2%) | $8.15 M(+1.9%) |
| Dec 2020 | $8.00 M(-24.7%) | $1.87 M(+1.0%) | $8.00 M(+1.9%) |
| Sep 2020 | - | $1.85 M(-19.0%) | $7.85 M(+3.1%) |
| Jun 2020 | - | $2.28 M(+14.2%) | $7.61 M(-23.9%) |
| Mar 2020 | - | $2.00 M(+16.3%) | $10.01 M(-5.8%) |
| Dec 2019 | $10.62 M(+47.0%) | $1.72 M(+6.5%) | $10.62 M(+4.5%) |
| Sep 2019 | - | $1.61 M(-65.5%) | $10.16 M(-2.6%) |
| Jun 2019 | - | $4.67 M(+78.9%) | $10.43 M(+23.7%) |
| Mar 2019 | - | $2.61 M(+107.8%) | $8.43 M(+16.7%) |
| Dec 2018 | $7.22 M(+48.7%) | $1.26 M(-33.4%) | $7.22 M(-0.8%) |
| Sep 2018 | - | $1.89 M(-29.4%) | $7.28 M(+8.6%) |
| Jun 2018 | - | $2.67 M(+90.6%) | $6.71 M(+31.4%) |
| Mar 2018 | - | $1.40 M(+6.8%) | $5.10 M(+5.0%) |
| Dec 2017 | $4.86 M | $1.31 M(+0.1%) | $4.86 M(-2.5%) |
| Sep 2017 | - | $1.31 M(+22.5%) | $4.98 M(-3.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2017 | - | $1.07 M(-7.5%) | $5.14 M(-8.6%) |
| Mar 2017 | - | $1.16 M(-19.4%) | $5.62 M(-15.3%) |
| Dec 2016 | $6.48 M(-36.9%) | $1.44 M(-2.4%) | $6.64 M(-6.1%) |
| Sep 2016 | - | $1.47 M(-5.1%) | $7.08 M(-16.7%) |
| Jun 2016 | - | $1.55 M(-28.7%) | $8.50 M(-12.8%) |
| Mar 2016 | - | $2.18 M(+16.3%) | $9.74 M(-5.2%) |
| Dec 2015 | $10.27 M(+17.4%) | $1.87 M(-35.3%) | $10.27 M(+1.5%) |
| Sep 2015 | - | $2.89 M(+3.5%) | $10.12 M(+5.9%) |
| Jun 2015 | - | $2.80 M(+3.3%) | $9.55 M(+1.2%) |
| Mar 2015 | - | $2.71 M(+57.0%) | $9.44 M(+7.9%) |
| Dec 2014 | $8.75 M(-10.9%) | $1.72 M(-25.8%) | $8.75 M(-5.7%) |
| Sep 2014 | - | $2.33 M(-13.4%) | $9.27 M(-8.9%) |
| Jun 2014 | - | $2.69 M(+33.4%) | $10.18 M(+1.9%) |
| Mar 2014 | - | $2.01 M(-10.6%) | $9.99 M(+1.8%) |
| Dec 2013 | $9.82 M(+179.6%) | $2.25 M(-30.4%) | $9.82 M(+10.3%) |
| Sep 2013 | - | $3.23 M(+29.4%) | $8.90 M(+40.2%) |
| Jun 2013 | - | $2.50 M(+35.9%) | $6.35 M(+35.7%) |
| Mar 2013 | - | $1.84 M(+37.8%) | $4.68 M(+33.2%) |
| Dec 2012 | $3.51 M(+5.3%) | $1.33 M(+96.6%) | $3.51 M(+7.1%) |
| Sep 2012 | - | $678.10 K(-18.1%) | $3.28 M(-15.4%) |
| Jun 2012 | - | $828.00 K(+23.2%) | $3.88 M(+1.9%) |
| Mar 2012 | - | $671.90 K(-39.0%) | $3.80 M(+13.3%) |
| Dec 2011 | $3.33 M(+209.2%) | $1.10 M(-13.5%) | $3.36 M(+26.6%) |
| Sep 2011 | - | $1.27 M(+68.3%) | $2.65 M(+47.1%) |
| Jun 2011 | - | $756.90 K(+235.8%) | $1.80 M(+68.1%) |
| Mar 2011 | - | $225.40 K(-43.2%) | $1.07 M(+26.6%) |
| Dec 2010 | $1.08 M | $396.70 K(-6.5%) | $847.00 K(+88.1%) |
| Sep 2010 | - | $424.20 K(+1525.3%) | $450.30 K(+364.7%) |
| Jun 2010 | - | $26.10 K(-63.1%) | $96.90 K(+36.9%) |
| Sep 2009 | - | $70.80 K | $70.80 K |
FAQ
- What is Atossa Therapeutics annual SGA?
- What is the all time high annual SGA for Atossa Therapeutics?
- What is Atossa Therapeutics annual SGA year-on-year change?
- What is Atossa Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Atossa Therapeutics?
- What is Atossa Therapeutics quarterly SGA year-on-year change?
- What is Atossa Therapeutics TTM SGA?
- What is the all time high TTM SGA for Atossa Therapeutics?
- What is Atossa Therapeutics TTM SGA year-on-year change?
What is Atossa Therapeutics annual SGA?
The current annual SGA of ATOS is $14.04 M
What is the all time high annual SGA for Atossa Therapeutics?
Atossa Therapeutics all-time high annual SGA is $14.04 M
What is Atossa Therapeutics annual SGA year-on-year change?
Over the past year, ATOS annual SGA has changed by +$1.44 M (+11.38%)
What is Atossa Therapeutics quarterly SGA?
The current quarterly SGA of ATOS is $2.97 M
What is the all time high quarterly SGA for Atossa Therapeutics?
Atossa Therapeutics all-time high quarterly SGA is $4.67 M
What is Atossa Therapeutics quarterly SGA year-on-year change?
Over the past year, ATOS quarterly SGA has changed by -$28.00 K (-0.93%)
What is Atossa Therapeutics TTM SGA?
The current TTM SGA of ATOS is -$782.11 M
What is the all time high TTM SGA for Atossa Therapeutics?
Atossa Therapeutics all-time high TTM SGA is -$384.80 K
What is Atossa Therapeutics TTM SGA year-on-year change?
Over the past year, ATOS TTM SGA has changed by -$795.95 M (-5754.79%)